학술논문

A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia
Document Type
Article
Source
In: Annals of Hematology. (Annals of Hematology, April 1992, 64(4):173-180)
Subject
Language
English
ISSN
09395555
14320584